Effect of influenza vaccination in the first trimester of pregnancy

Jeanne S. Sheffield, Laura G. Greer, Vanessa L. Rogers, Scott W. Roberts, Heather Lytle, Donald D. McIntire, George D. Wendel

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Objective: To estimate the effect of first-trimester influenza vaccination on fetal and neonatal outcomes. Methods: This was a retrospective cohort study examining delivery and neonatal outcomes after antepartum exposure to the seasonal trivalent inactive influenza vaccine. Data were collected and entered into an established computerized database. Outcomes by trimester of vaccination were then compared with women who did not receive the vaccine. Results: During the 5-year study period, 10,225 women received the seasonal influenza vaccine antepartum; 8,690 of these delivered at our institution, 439 in the first trimester and 8,251 in the second and third trimesters. Women vaccinated antepartum were significantly older with higher parity than women who declined vaccination. Neonates born to mothers receiving the vaccine in any trimester did not have an increase in major malformations regardless of trimester of vaccination (2% regardless of vaccination group, P=.9). Stillbirth (0.3% compared with 0.6%, P=.006), neonatal death (0.2% compared with 0.4%, P=.01), and premature delivery (5% compared with 6%, P=.004) were significantly decreased in the vaccinated group. Conclusion: Influenza vaccination in the first trimester was not associated with an increase in major malformation rates and was associated with a decrease in the overall stillbirth rate. This information will aid in counseling women regarding the safety of influenza vaccination in the first trimester.

Original languageEnglish (US)
Pages (from-to)532-537
Number of pages6
JournalObstetrics and Gynecology
Volume120
Issue number3
DOIs
StatePublished - Sep 2012

Fingerprint

First Pregnancy Trimester
Human Influenza
Vaccination
Stillbirth
Influenza Vaccines
Vaccines
Third Pregnancy Trimester
Second Pregnancy Trimester
Parity
Counseling
Cohort Studies
Retrospective Studies
Mothers
Newborn Infant
Databases
Safety

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Effect of influenza vaccination in the first trimester of pregnancy. / Sheffield, Jeanne S.; Greer, Laura G.; Rogers, Vanessa L.; Roberts, Scott W.; Lytle, Heather; McIntire, Donald D.; Wendel, George D.

In: Obstetrics and Gynecology, Vol. 120, No. 3, 09.2012, p. 532-537.

Research output: Contribution to journalArticle

Sheffield, Jeanne S. ; Greer, Laura G. ; Rogers, Vanessa L. ; Roberts, Scott W. ; Lytle, Heather ; McIntire, Donald D. ; Wendel, George D. / Effect of influenza vaccination in the first trimester of pregnancy. In: Obstetrics and Gynecology. 2012 ; Vol. 120, No. 3. pp. 532-537.
@article{b14c560c684146d4b274ed27d76925aa,
title = "Effect of influenza vaccination in the first trimester of pregnancy",
abstract = "Objective: To estimate the effect of first-trimester influenza vaccination on fetal and neonatal outcomes. Methods: This was a retrospective cohort study examining delivery and neonatal outcomes after antepartum exposure to the seasonal trivalent inactive influenza vaccine. Data were collected and entered into an established computerized database. Outcomes by trimester of vaccination were then compared with women who did not receive the vaccine. Results: During the 5-year study period, 10,225 women received the seasonal influenza vaccine antepartum; 8,690 of these delivered at our institution, 439 in the first trimester and 8,251 in the second and third trimesters. Women vaccinated antepartum were significantly older with higher parity than women who declined vaccination. Neonates born to mothers receiving the vaccine in any trimester did not have an increase in major malformations regardless of trimester of vaccination (2{\%} regardless of vaccination group, P=.9). Stillbirth (0.3{\%} compared with 0.6{\%}, P=.006), neonatal death (0.2{\%} compared with 0.4{\%}, P=.01), and premature delivery (5{\%} compared with 6{\%}, P=.004) were significantly decreased in the vaccinated group. Conclusion: Influenza vaccination in the first trimester was not associated with an increase in major malformation rates and was associated with a decrease in the overall stillbirth rate. This information will aid in counseling women regarding the safety of influenza vaccination in the first trimester.",
author = "Sheffield, {Jeanne S.} and Greer, {Laura G.} and Rogers, {Vanessa L.} and Roberts, {Scott W.} and Heather Lytle and McIntire, {Donald D.} and Wendel, {George D.}",
year = "2012",
month = "9",
doi = "10.1097/AOG.0b013e318263a278",
language = "English (US)",
volume = "120",
pages = "532--537",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Effect of influenza vaccination in the first trimester of pregnancy

AU - Sheffield, Jeanne S.

AU - Greer, Laura G.

AU - Rogers, Vanessa L.

AU - Roberts, Scott W.

AU - Lytle, Heather

AU - McIntire, Donald D.

AU - Wendel, George D.

PY - 2012/9

Y1 - 2012/9

N2 - Objective: To estimate the effect of first-trimester influenza vaccination on fetal and neonatal outcomes. Methods: This was a retrospective cohort study examining delivery and neonatal outcomes after antepartum exposure to the seasonal trivalent inactive influenza vaccine. Data were collected and entered into an established computerized database. Outcomes by trimester of vaccination were then compared with women who did not receive the vaccine. Results: During the 5-year study period, 10,225 women received the seasonal influenza vaccine antepartum; 8,690 of these delivered at our institution, 439 in the first trimester and 8,251 in the second and third trimesters. Women vaccinated antepartum were significantly older with higher parity than women who declined vaccination. Neonates born to mothers receiving the vaccine in any trimester did not have an increase in major malformations regardless of trimester of vaccination (2% regardless of vaccination group, P=.9). Stillbirth (0.3% compared with 0.6%, P=.006), neonatal death (0.2% compared with 0.4%, P=.01), and premature delivery (5% compared with 6%, P=.004) were significantly decreased in the vaccinated group. Conclusion: Influenza vaccination in the first trimester was not associated with an increase in major malformation rates and was associated with a decrease in the overall stillbirth rate. This information will aid in counseling women regarding the safety of influenza vaccination in the first trimester.

AB - Objective: To estimate the effect of first-trimester influenza vaccination on fetal and neonatal outcomes. Methods: This was a retrospective cohort study examining delivery and neonatal outcomes after antepartum exposure to the seasonal trivalent inactive influenza vaccine. Data were collected and entered into an established computerized database. Outcomes by trimester of vaccination were then compared with women who did not receive the vaccine. Results: During the 5-year study period, 10,225 women received the seasonal influenza vaccine antepartum; 8,690 of these delivered at our institution, 439 in the first trimester and 8,251 in the second and third trimesters. Women vaccinated antepartum were significantly older with higher parity than women who declined vaccination. Neonates born to mothers receiving the vaccine in any trimester did not have an increase in major malformations regardless of trimester of vaccination (2% regardless of vaccination group, P=.9). Stillbirth (0.3% compared with 0.6%, P=.006), neonatal death (0.2% compared with 0.4%, P=.01), and premature delivery (5% compared with 6%, P=.004) were significantly decreased in the vaccinated group. Conclusion: Influenza vaccination in the first trimester was not associated with an increase in major malformation rates and was associated with a decrease in the overall stillbirth rate. This information will aid in counseling women regarding the safety of influenza vaccination in the first trimester.

UR - http://www.scopus.com/inward/record.url?scp=84865663784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865663784&partnerID=8YFLogxK

U2 - 10.1097/AOG.0b013e318263a278

DO - 10.1097/AOG.0b013e318263a278

M3 - Article

C2 - 22914461

AN - SCOPUS:84865663784

VL - 120

SP - 532

EP - 537

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 3

ER -